hnRNP D0 Inhibitors
hnRNP D0 inhibitors are a class of chemical compounds that target and interact with hnRNP D0, also known as heterogeneous nuclear ribonucleoprotein D0. hnRNP D0 is a protein involved in RNA processing and regulation, particularly in the context of pre-mRNA splicing. It is a member of the hnRNP family, which plays a crucial role in controlling gene expression and RNA metabolism within the nucleus of eukaryotic cells. Inhibitors of hnRNP D0 are designed to modulate its activity or interactions with other molecules, ultimately influencing the splicing patterns of specific genes.
These inhibitors typically work by binding to hnRNP D0 and disrupting its normal functions. They may interfere with its ability to interact with RNA molecules, other proteins, or various regulatory elements in the cell nucleus. As a result, the inhibitors can impact the alternative splicing of pre-mRNA transcripts, leading to altered isoform production of specific genes. This modulation of alternative splicing can have profound effects on gene expression patterns, influencing cellular processes and functions. Researchers are actively studying hnRNP D0 inhibitors to better understand their mechanisms of action and explore their applications in various biological contexts, including the development of certain interventions.
SEE ALSO...
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Trichostatin A | 58880-19-6 | sc-3511 sc-3511A sc-3511B sc-3511C sc-3511D | 1 mg 5 mg 10 mg 25 mg 50 mg | $152.00 $479.00 $632.00 $1223.00 $2132.00 | 33 | |
A histone deacetylase inhibitor, it might affect chromatin structure and hnRNP D gene expression. | ||||||
Rocaglamide | 84573-16-0 | sc-203241 sc-203241A sc-203241B sc-203241C sc-203241D | 100 µg 1 mg 5 mg 10 mg 25 mg | $275.00 $474.00 $1639.00 $2497.00 $5344.00 | 4 | |
Has been shown to inhibit translation initiation, and could potentially affect hnRNP D production. | ||||||
Silvestrol | 697235-38-4 | sc-507504 | 1 mg | $920.00 | ||
Like rocaglamide, it is known to inhibit translation initiation and might affect hnRNP D levels. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $63.00 $158.00 $326.00 | 233 | |
By inhibiting the mTOR pathway, it could lead to reduced protein synthesis, potentially affecting hnRNP D levels. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
Inhibiting the PI3K/Akt/mTOR pathway could lead to reduced hnRNP D synthesis. | ||||||
PD 98059 | 167869-21-8 | sc-3532 sc-3532A | 1 mg 5 mg | $40.00 $92.00 | 212 | |
Could potentially influence cell signaling pathways that regulate hnRNP D expression. | ||||||
SP600125 | 129-56-6 | sc-200635 sc-200635A | 10 mg 50 mg | $40.00 $150.00 | 257 | |
May modulate stress and inflammatory response pathways that influence hnRNP D levels. | ||||||
Bortezomib | 179324-69-7 | sc-217785 sc-217785A | 2.5 mg 25 mg | $135.00 $1085.00 | 115 | |
Typically increases protein levels but might selectively affect hnRNP D turnover in certain contexts. | ||||||
Geldanamycin | 30562-34-6 | sc-200617B sc-200617C sc-200617 sc-200617A | 100 µg 500 µg 1 mg 5 mg | $39.00 $59.00 $104.00 $206.00 | 8 | |
Could potentially disrupt the proper folding and function of hnRNP D. | ||||||
Chloroquine | 54-05-7 | sc-507304 | 250 mg | $69.00 | 2 | |
Might influence hnRNP D levels by affecting autophagic turnover of cellular components. | ||||||